Priv.-Doz. Dr. rer. nat. Volker Burkart

Ausgewählte Publikationen

• Karusheva Y, Koessler T, Strassburger K, Markgraf D, Mastrototaro L, Jelenik T, Simon M-C, Pesta D, Zaharia O-P, Bódis K, Bärenz F, Schmoll D, Wolkersdorfer M, Tura A, Pacini G, Burkart V, Müssig K, Szendroedi J, Roden M 2019. Short-term dietary reduction of branched-chain amino acids reduces meal-induced insulin secretion and modifies microbiome composition in type 2 diabetes: a randomized controlled crossover trial. Am J Clin Nutr. 110: 1098-1107. https://doi.org/10.1093/ajcn/nqz191
• Zaharia O-P, Strassburger K, Strom A, Bönhof G, Karusheva Y, Antoniou S, Bódis K, Markgraf D, Burkart V, Müssig K, Hwang JH, Asplund O, Groop L, Ahlqvist E, Seissler J, Nawroth P, Kopf S, Schmid SM, Stumvoll M, Pfeiffer A, Kabisch S, Tselmin S, Häring H-U, Ziegler D, Kuß O, Szendrödi J, Roden M for the GDS Group 2019. Risk of diabetes-associated diseases in subgroups of patients with recent-onset diabetes: a 5-year follow-up study. Lancet Diabetes Endocrinol. 7: 684-694. https://doi.org/10.1016/S2213-8587(19)30187-1
• Bódis K, Jelenik T, Lundbom J, Markgraf DF, Strom A, Zaharia O-P, Karusheva Y, Burkart V, Müssig K, Kupriyanova Y, Ouni M, Wolkersdorfer M, Ziegler D, Hwang J-H, Schürmann A, Roden M, Szendroedi J for the GDS Group 2019. Expansion and impaired mitochondrial efficiency of deep subcutaneous adipose tissue in recent-onset type 2 diabetes. J Clin Endocrinol Metab. in press. https://doi.org/10.1210/clinem/dgz267
• Simon M-C, Reinbeck AL, Wessel C, Heindirk J, Jelenik T, Kaul K, Arreguin-Cano J, Strom A, Blaut M, Bäckhed F, Burkart V, Roden M 2019. Distinct alterations of gut morphology and microbiota characterize accelerated diabetes onset in non-obese diabetic mice. J Biol Chem. in press. https://doi.org/10.1074/jbc.RA119.010816
• Zaharia OP, Bobrov P, Strassburger K, Bódis K, Karusheva Y, Scholz M, Markgraf DF, Burkart V, Schloot NC., Müssig K, Szendroedi J, Roden M for the GDS Group 2018. Metabolic Characteristics of Recently Diagnosed Adult-onset Autoimmune Diabetes Mellitus. J Clin Endocrinol Metab. 103: 429-437. https://doi.org/10.1210/jc.2017-01706
• Szendroedi J, Saxena A, Weber KS, Strassburger K, Herder C, Burkart V, Nowotny B, Icks A, Kuss O, Ziegler D, Al-Hasani H, Müssig K, Roden M for the GDS Group 2016. Cohort profile: the German Diabetes Study (GDS). Cardiovasc Diabetol. 15. https://doi.org/10.1186/s12933-016-0374-9
• Weber KS., Knebel B, Straßburger K, Kotzka J, Stehle P, Szendrödi J, Müssig K, Buyken AE, Roden M for the GDS Group 2016. Associations between explorative dietary patterns and serum lipid levels and their interactions with ApoA5 and ApoE haplotype in patients with recently diagnosed type 2 diabetes. Cardiovasc Diabetol. 15. https://doi.org/10.1186/s12933-016-0455-9
• Weber KS, Nowotny B, Strassburger K, Pacini G, Müssig K, Szendroedi J, Herder C, Roden M for the GDS Group 2015. The Role of Markers of Low-Grade Inflammation for the Early Time Course of Glycemic Control, Glucose Disappearance Rate, and β-Cell Function in Recently Diagnosed Type 1 and Type 2 Diabetes. Diabetes Care. 38: 1758-1767. https://doi.org/10.2337/dc15-0169
• Simon M-C, Strassburger K, Nowotny B, Kolb H, Nowotny P, Burkart V, Zivehe F, Hwang JH, Stehle P, Pacini G, Hartmann B, Holst JJ, MacKenzie C, Bindels LB, Martinez I, Walter J, Henrich B, Schloot NC, Roden M 2015. Intake of Lactobacillus reuteri Improves Incretin and Insulin Secretion in Glucose Tolerant Humans: A Proof of Concept. Diabetes Care. 38: 1827-1834. https://doi.org/10.2337/dc14-2690